Bliss GVS Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bliss GVS Pharma Ltd. on BSE

Search Inside the pdf :

Bliss GVS Pharma Ltd.

29 Jul 2025, 06:37PM

183.17

17.78%

Company Update

Bliss GVS Pharma Ltd - 506197 - Grant Of Options Under Bliss GVS Pharma Limited - …

BSE India

Grant of 2,68,000 stock options under Bliss GVS Pharma Limited - Employee Stock Option Plan 2019.

pdf

Bliss GVS Pharma Ltd.

29 Jul 2025, 06:25PM

183.17

17.78%

Result

Bliss GVS Pharma Ltd - 506197 - Outcome Of Board Meeting Held On Tuesday, July 29, …

BSE India

We wish to inform you that the Board of Directors at its meeting held today i.e. Tuesday, July 29, 2025 has considered and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	242.92	210.05	187.77	15.6%	29.4%
Operating Profit Qtr	41.33	21.09	34.33	96.0%	20.4%
Net Profit Qtr	43.04	15.54	20.70	177.0%	107.9%
Earning Per Share Adjusted latest Qtr	4.08	1.47	1.96	177.6%	108.2%

* Consolidated data

Detailed Results

Bliss GVS Pharma Ltd.

29 Jul 2025, 06:17PM

183.17

17.78%

Board Meeting

Bliss GVS Pharma Ltd - 506197 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

We would like to inform you that, the Board Meeting of the Company was held today i.e. on Tuesday, July 29, 2025 at the registered office of the Company. In pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has considered and approved the the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2025. A copy of unaudited standalone and consolidated financial results along with the Limited Review Report of the Auditors.

pdf

Bliss GVS Pharma Ltd.

28 Jul 2025

183.17

17.78%

Company Update

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

We would like to inform you that the ESOP Allotment Committee at its meeting held on July 28, 2025, has approved the allotment of 74,000 equity shares of face value Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan ("Bliss GVS ESOP-2019")

pdf

Bliss GVS Pharma Ltd.

22 Jul 2025

183.17

17.78%

Board Meeting

Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial …

BSE India

Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2025. Please find enclosed intimation in this regard

pdf

Bliss GVS Pharma Ltd.

10 Jul 2025

183.17

17.78%

Company Update

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith Newspaper Advertisement of Notice of 40th Annual General Meeting, e-voting and Book Closure Information.

pdf

Bliss GVS Pharma Ltd.

09 Jul 2025

183.17

17.78%

Corp. Note

Bliss GVS Pharma Ltd - 506197 - Business Responsibility and Sustainability Reporting (BRSR)

BSE India

Please find enclosed herewith the Business Responsibility and Sustainability Report for the FY 2024-2025.

pdf

Bliss GVS Pharma Ltd.

09 Jul 2025

183.17

17.78%

AGM

Bliss GVS Pharma Ltd - 506197 - Notice Of The 40Th Annual General Meeting ('40Th AGM') …

BSE India

Please find enclosed herewith the Notice of the 40th AGM of Bliss GVS Pharma Limited ("the Company") scheduled to be held on Thursday, July 31, 2025, at 11:30 A.M. (IST) through VC/OAVM. The said Notice forms part of the Annual Report of the Company for the FY 2024-2025.

pdf

Bliss GVS Pharma Ltd.

09 Jul 2025

183.17

17.78%

Corp. Note

Bliss GVS Pharma Ltd - 506197 - Reg. 34 (1) Annual Report.

BSE India

Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), please find enclosed the Notice convening the 40th AGM and the Annual Report of the Company including Business Responsibility and Sustainability Report, for the financial year 2024-2025.

pdf